Skip to main content
Terug
Watch Compare

HeartSciences Inc.

Datakwaliteit: 100%
Ook genoteerd als HSCSW Nasdaq
HSCS
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 2,08
▼ € 0,08 (-3,70%)
Marktkapitalisatie: 6,88 M
Prijs
€ 2,16
Marktkapitalisatie
6,88 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Net margin of 229705,35% shows strong profitability
Negative free cash flow of -11,65 M
Capital efficient — spends only -295,51% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-76,61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-580,83%
Onder sectorgemiddelde (-53,34%)
ROIC-342,48%
Net Margin229705,35%
Op. Margin209272,68%

Veiligheid

Debt / Equity
N/A
Current Ratio1,19
Interest Coverage-10,05

Waardering

PE (TTM)
-0,53
Boven sectorgemiddelde (-1,47)
P/B Ratio2,59
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,5 -1,5
P/B 2,6 1,6
ROE % -580,8 -53,3
Net Margin % 229705,4 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

2 analisten
Strong Buy
Huidig
€ 2,08
+380.8%
Koersdoel
€ 10,00
€ 8,00
€ 10,00
€ 12,00
Vooruitzicht
Forward K/W -0,74
Forward WPA -€ 2,83
Omzet Sch. 357.500,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 2,83
-€ 3,10 – -€ 2,55
 357.500,0 2
FY2026 -€ 3,38
-€ 3,47 – -€ 3,28
 4.300,0 2

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q12026 -€ 0,88 -€ 0,63 +28,4%
Q42025 -€ 1,28 -€ 0,85 +33,3%
Q32025 -€ 1,88 -€ 1,58 +15,7%
Q22025 -€ 2,15 -€ 1,88 +12,4%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -76,61% Revenue Growth (3Y) -8,09%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) -5.612,0 Net Income (TTM) -12,89 M
ROE -580,83% ROA -194,46%
Gross Margin 88,15% Operating Margin 209272,68%
Net Margin 229705,35% Free Cash Flow (TTM) -11,65 M
ROIC -342,48% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,19
Interest Coverage -10,05 Asset Turnover 0,00
Working Capital 829.925 Tangible Book Value 994.948
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,53 Forward P/E N/A
P/B Ratio 2,59 P/S Ratio -1225,76
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -169,28%
Market Cap 6,88 M Enterprise Value 3,48 M
Per Share
EPS (Diluted TTM) -3,98 Revenue / Share 0,00
FCF / Share -3,66 OCF / Share -3,65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue -295,51% FCF Conversion 90,33%
SBC-Adj. FCF -12,79 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 4.350,0 18.600,0 5.150,0
Net Income -8,77 M -6,61 M -6,35 M
EPS (Diluted) -9,34 -19,00 -0,80
Gross Profit 2.470,0 12.519,0 2.354,0
Operating Income -8,35 M -6,31 M -6,11 M
EBITDA — — —
R&D Expenses 4,39 M 2,88 M 2,46 M
SG&A Expenses 3,97 M 3,44 M 3,65 M
D&A — — —
Interest Expense 500.453,0 354.080,0 243.174,0
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 4,22 M 9,50 M 3,29 M
Total Liabilities 4,02 M 2,19 M 3,06 M
Shareholders' Equity 205.171,0 7,32 M 230.557,0
Total Debt — — —
Cash & Equivalents 1,10 M 5,81 M 1,66 M
Current Assets 2,17 M 7,35 M 2,70 M
Current Liabilities 3,70 M 1,75 M 1,83 M